CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 162 filers reported holding CARA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,338 | -60.6% | 10,320 | -33.7% | 0.00% | – |
| Q2 2023 | $44,029 | -84.2% | 15,558 | -72.6% | 0.00% | – |
| Q1 2023 | $278,785 | -54.9% | 56,779 | -1.3% | 0.00% | -100.0% |
| Q4 2022 | $617,958 | +16.2% | 57,538 | +1.2% | 0.00% | 0.0% |
| Q3 2022 | $532,000 | +1.5% | 56,877 | -0.9% | 0.00% | 0.0% |
| Q2 2022 | $524,000 | -23.6% | 57,385 | +1.7% | 0.00% | 0.0% |
| Q1 2022 | $686,000 | -2.6% | 56,453 | -2.4% | 0.00% | 0.0% |
| Q4 2021 | $704,000 | -19.7% | 57,834 | +1.9% | 0.00% | 0.0% |
| Q3 2021 | $877,000 | +0.3% | 56,767 | -7.3% | 0.00% | 0.0% |
| Q2 2021 | $874,000 | -35.3% | 61,260 | -1.5% | 0.00% | -50.0% |
| Q1 2021 | $1,350,000 | +43.5% | 62,170 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $941,000 | +19.0% | 62,170 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $791,000 | -24.4% | 62,170 | +1.6% | 0.00% | -50.0% |
| Q2 2020 | $1,046,000 | +31.7% | 61,182 | +1.7% | 0.00% | 0.0% |
| Q1 2020 | $794,000 | -19.0% | 60,141 | -1.1% | 0.00% | 0.0% |
| Q4 2019 | $980,000 | -13.6% | 60,820 | -2.0% | 0.00% | 0.0% |
| Q3 2019 | $1,134,000 | +0.4% | 62,049 | +18.2% | 0.00% | 0.0% |
| Q2 2019 | $1,129,000 | +15.3% | 52,502 | +5.3% | 0.00% | 0.0% |
| Q1 2019 | $979,000 | +47.7% | 49,877 | -2.2% | 0.00% | 0.0% |
| Q4 2018 | $663,000 | -44.5% | 51,021 | +2.4% | 0.00% | 0.0% |
| Q3 2018 | $1,194,000 | +50.2% | 49,836 | +20.1% | 0.00% | 0.0% |
| Q2 2018 | $795,000 | +58.7% | 41,491 | +2.5% | 0.00% | +100.0% |
| Q1 2018 | $501,000 | -2.9% | 40,475 | -3.9% | 0.00% | 0.0% |
| Q4 2017 | $516,000 | -13.0% | 42,119 | -2.7% | 0.00% | 0.0% |
| Q3 2017 | $593,000 | -18.7% | 43,299 | -8.6% | 0.00% | -50.0% |
| Q2 2017 | $729,000 | -4.2% | 47,354 | +14.5% | 0.00% | 0.0% |
| Q1 2017 | $761,000 | +89.3% | 41,354 | -4.4% | 0.00% | +100.0% |
| Q4 2016 | $402,000 | +8.4% | 43,254 | -2.7% | 0.00% | 0.0% |
| Q3 2016 | $371,000 | +75.0% | 44,454 | +0.9% | 0.00% | – |
| Q2 2016 | $212,000 | -20.3% | 44,054 | +3.1% | 0.00% | -100.0% |
| Q1 2016 | $266,000 | -57.2% | 42,729 | +16.0% | 0.00% | -50.0% |
| Q4 2015 | $621,000 | +20.1% | 36,820 | +1.7% | 0.00% | +100.0% |
| Q3 2015 | $517,000 | +39.7% | 36,193 | +18.7% | 0.00% | 0.0% |
| Q2 2015 | $370,000 | +273.7% | 30,493 | +208.0% | 0.00% | – |
| Q1 2015 | $99,000 | 0.0% | 9,899 | 0.0% | 0.00% | – |
| Q4 2014 | $99,000 | +19.3% | 9,899 | +0.4% | 0.00% | – |
| Q3 2014 | $83,000 | -50.3% | 9,856 | +0.6% | 0.00% | – |
| Q2 2014 | $167,000 | -8.2% | 9,800 | 0.0% | 0.00% | – |
| Q1 2014 | $182,000 | – | 9,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |